NCT04751396View on ClinicalTrials.gov

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Ankylosing SpondylitisAutoimmune DiseaseCrohn DiseaseEnteropathic ArthritisEnteropathic SpondylitisInflammatory Bowel DiseaseMelanomaPsoriasisPsoriatic ArthritisReactive ArthritisRheumatoid ArthritisSystemic Lupus ErythematosusUlcerative Colitis
Interventions
OTHER

Best Practice

Receive standard educational information

OTHER

Educational Intervention

Navigate educational tool

OTHER

Interview

Participate in interview

OTHER

Questionnaire Administration

Complete questionnaire

OTHER

Survey Administration

Complete surveys

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER